Endometriosis study seeks the most satisfying hormone combo
NCT ID NCT07204093
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at two different hormone combinations for treating endometriosis: drospirenone plus estradiol, or dienogest plus estradiol. Researchers want to know which one women are more satisfied with after six months of use. The study involves 138 women and focuses on patient preference and symptom control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Drospirenone 4 mg orally plus transdermal estradiol, or Dienogest 2 mg orally plus transdermal estradiol
What this could lead to
If successful, this could help doctors choose the hormone therapy that women with endometriosis find most satisfying, improving long-term treatment adherence.
What could go wrong
This is a small, observational study comparing existing treatments, not testing a new drug. Results may not apply to all women, and satisfaction is subjective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy